Clinical chemistry tests for patients with COVID-19 – important caveats for interpretation

Please use this identifier to cite or link to this item: http://hdl.handle.net/11375/26244

Full metadata record

DC Field	Value	Language
dc.contributor.author	Kavsak PA	-
dc.contributor.author	de Wit K	-
dc.contributor.author	Worster A	-
dc.date.accessioned	2021-02-25T20:39:27Z	-
dc.date.available	2021-02-25T20:39:27Z	-
dc.date.issued	2020-06-25	-
dc.identifier.issn	1434-6621	-
dc.identifier.issn	1437-4331	-
dc.identifier.uri	http://hdl.handle.net/11375/26244	-
dc.publisher	Walter de Gruyter GmbH	-
dc.subject	COVID-19	-
dc.subject	analytical	-
dc.subject	clinical chemistry	-
dc.subject	emergency setting	-
dc.subject	postanalytical	-
dc.subject	preanalytical	-
dc.subject	Betacoronavirus	-
dc.subject	Blood Gas Analysis	-
dc.subject	COVID-19	-
dc.subject	Chemistry, Clinical	-
dc.subject	Clinical Chemistry Tests	-
dc.subject	Clinical Laboratory Techniques	-
dc.subject	Coronavirus Infections	-
dc.subject	Humans	-
dc.subject	Pandemics	-
dc.subject	Pneumonia, Viral	-
dc.subject	SARS-CoV-2	-
dc.subject	Urea	-
dc.title	Clinical chemistry tests for patients with COVID-19 – important caveats for interpretation	-
dc.type	Article	-
dc.date.updated	2021-02-25T20:39:26Z	-
dc.identifier.doi	https://doi.org/10.1515/cclm-2020-0436	-
Appears in Collections:	Faculty Publications (via McMaster Experts)

Files in This Item:

File	Description	Size	Format
10.1515_cclm-2020-0436.pdf Open Access	Published version	65.27 kB	Adobe PDF	View/Open